ClinicalTrials.govpublic full text
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
systemic lupus erythematosus, cd19, car, allogeneic, nkx019, cell therapy, lupus nephritis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 876817
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.